EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Antimicrobial Peptides Demonstrate Activity against Resistant Bacterial Pathogens

Mary Garvey iD

Infectious Disease Reports · 14.08.2023 · 15 (4) · 454-469

DOI: 10.3390/idr15040046 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Infectious Disease Reports, online erschienen am 14.08.2023. Verfasst von Mary Garvey. Beteiligte Einrichtung: Department of Life Science, Atlantic Technological University, F91YW50 Sligo, Ireland. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The antimicrobial resistance crisis is an ongoing major threat to public health safety. Low- and middle-income countries are particularly susceptible to higher fatality rates and the economic impact of antimicrobial resistance (AMR). As an increasing number of pathogens emerge with multi- and pan-drug resistance to last-resort antibiotics, there is an urgent need to provide alternative antibacterial options to mitigate disease transmission, morbidity, and mortality. As identified by the World Health Organization (WHO), critically important pathogens such as Klebsiella and Pseudomonas species are becoming resistant to last-resort antibiotics including colistin while being frequently isolated from clinical cases of infection. Antimicrobial peptides are potent amino acid sequences produced by many life forms from prokaryotic, fungal, plant, to animal species. These peptides have many advantages, including their multi-hit mode of action, potency, and rapid onset of action with low levels of resistance being evident. These innate defense mechanisms also have an immune-stimulating action among other activities in vivo, thus making them ideal therapeutic options. Large-scale production and formulation issues (pharmacokinetics, pharmacodynamics), high cost, and protease instability hinder their mass production and limit their clinical application. This review outlines the potential of these peptides to act as therapeutic agents in the treatment of multidrug-resistant infections considering the mode of action, resistance, and formulation aspects. Clinically relevant Gram-positive and Gram-negative pathogens are highlighted according to the WHO priority pathogen list.

Schlagwörter

Stichwörter der Autor:innen

antimicrobial peptideinfectious diseasepotentresistancetherapeutic

Autor:innen und Institutionen

  • Department of Life Science, Atlantic Technological University, F91YW50 Sligo, Ireland.
  • Centre for Precision Engineering, Materials and Manufacturing Research (PEM), Atlantic Technological University, F91YW50 Sligo, Ireland.

ORCID-Profile: Mary Garvey

Zitieren

APA

Garvey, M. (2023). Antimicrobial Peptides Demonstrate Activity against Resistant Bacterial Pathogens. Infectious Disease Reports, 15(4), 454-469. https://doi.org/10.3390/idr15040046

Vancouver

Garvey M. Antimicrobial Peptides Demonstrate Activity against Resistant Bacterial Pathogens. Infectious Disease Reports. 2023;15(4):454-469. doi:10.3390/idr15040046

BibTeX
@article{Garvey2023,
  author = {Garvey, Mary},
  title = {Antimicrobial Peptides Demonstrate Activity against Resistant Bacterial Pathogens},
  journal = {Infectious Disease Reports},
  year = {2023},
  volume = {15},
  number = {4},
  pages = {454--469},
  doi = {10.3390/idr15040046}
}
Kostenlos starten →